Literature DB >> 19005027

Biotransformation of drugs in human skin.

Craig K Svensson1.   

Abstract

Although it is the largest organ of the human body, skin is often not considered in discussions of drug metabolism. However, there is growing evidence that most common drug-metabolizing enzymes are expressed in the skin. Evidence for expression of cytochromes P450, flavin monooxygenases, glutathione-S-transferases, N-acetyltransferases, and sulfotransferases in human skin and skin cells are presented. Additional discussion is focused on the evidence of actual metabolism of drugs. Finally, the potential clinical implications of metabolism within the skin are discussed briefly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005027     DOI: 10.1124/dmd.108.024794

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

1.  Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.

Authors:  Keith K Burkhart; Darrell Abernethy; David Jackson
Journal:  J Med Toxicol       Date:  2015-06

2.  [After the outlawing of animal experimentation. How can research go on?].

Authors:  C Götz
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

3.  Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouse.

Authors:  Lisbeth K Siddens; Kristi L Bunde; Tod A Harper; Tammie J McQuistan; Christiane V Löhr; Lisa M Bramer; Katrina M Waters; Susan C Tilton; Sharon K Krueger; David E Williams; William M Baird
Journal:  Toxicol Appl Pharmacol       Date:  2015-06-03       Impact factor: 4.219

4.  Investigation of cis-trans isomer dependent dermatotoxicokinetics of UV filter ethylhexyl methoxycinnamate through stratum corneum in vivo.

Authors:  Anežka Sharma; Katarína Bányiová; Branislav Vrana; Ivan Justan; Pavel Čupr
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-17       Impact factor: 4.223

5.  Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.

Authors:  Guinevere H Bell; Andrew J Novak; William C Griffin; Kennerly S Patrick
Journal:  J Pharm Sci       Date:  2011-01-14       Impact factor: 3.534

6.  Investigations on detoxification mechanisms of novel para-phenylenediamine analogues through N-acetyltransferase 1 (NAT-1).

Authors:  Gopalakrishnan Venkatesan; Zhi Chiaw Lim; Aneesh V Karkhanis; Yub Raj Neupane; Yuri Dancik; Chenyuan Huang; Paul Bigliardi; Giorgia Pastorin
Journal:  Arch Toxicol       Date:  2021-11-12       Impact factor: 5.153

7.  Minimization of CYP2D6 Polymorphic Differences and Improved Bioavailability via Transdermal Administration: Latrepirdine Example.

Authors:  Marci L Chew; Joyce Mordenti; Thean Yeoh; Gautam Ranade; Ruolun Qiu; Juanzhi Fang; Yali Liang; Brian Corrigan
Journal:  Pharm Res       Date:  2016-04-12       Impact factor: 4.200

8.  Decreased skin-mediated detoxification contributes to oxidative stress and insulin resistance.

Authors:  Xing-Xing Liu; Chang-Bin Sun; Ting-Tong Yang; Da Li; Chun-Yan Li; Yan-Jie Tian; Ming Guo; Yu Cao; Shi-Sheng Zhou
Journal:  Exp Diabetes Res       Date:  2012-08-01

Review 9.  Deleterious effects of reactive metabolites.

Authors:  Sabry M Attia
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

Review 10.  Mechanisms and the clinical relevance of complex drug-drug interactions.

Authors:  Arthur G Roberts; Morgan E Gibbs
Journal:  Clin Pharmacol       Date:  2018-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.